ACT CAPITAL MANAGEMENT, LLC Adaptimmune Therapeutics plc Transaction History

ACT CAPITAL MANAGEMENT, LLC portfolio value:

$97,000
portfolio value

ACT CAPITAL MANAGEMENT, LLC quarter portfolio value change:

-36.76%
quarter

Adaptimmune Therapeutics plc 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -56K $1.08 90K
Q2 2022 share 0.00% 0 shares -32K $1.7 90K
Q1 2022 share 0.00% 0 shares -153K $2.06 90K
Q4 2021 share 0.00% 0 shares -127K $3.87 90K
Q3 2021 share Increase 0.00% 90K shares 465K $5.17 90K